Tenet Healthcare Corporation New vs Eli Lilly & Co.
THC vs LLY — side-by-side comparison from reported financials. THC leads 2, LLY leads 9 of 11 comparable metrics.
Tenet Healthcare Corporation New
THC · Healthcare
$264.31+1.44%Mixed
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | THC | LLY |
|---|---|---|
| Price | $264.31 | $1 177.20 |
| Market cap | $21.3B | $1.05T |
| Revenue (TTM) | $21.8B | $79.7B |
| Revenue growth | +3.6% | +31.7% |
| Net margin | 10.3% | 33.5% |
| Free cash flow | $3.02B | $18.2B |
| Net cash (debt) | ($10.3B) | ($35.2B) |
| 1-year price return | +35.6% | +37.6% |
| P/E | 9.5 | 41.6 |
| P/E vs own history (cheap-side %) | 50% | 88% |
| Dividend yield | — | 0.52% |
| Return on equity | 51% | 93% |
| Altman Z-score | 1.51 | 7.10 |
| CV checks passed | 9 of 10 | 11 of 10 |
| Employees | 99,000 | 50,000 |
Full résumé-style profiles: THC CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.